Recent Updates
Recently added Catalysts

Full dose preparation

Phase 2

Colonoscopy Preparation | Small molecule | Other |Cumberland Pharmaceuticals Inc.|Last Updated: Jun 1, 2015

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindCONTROLLEDBiomarker
Total Trials1
Total Enrollment55
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT018874702 Regimens of Lactulose for Colonoscopy Preparation in AdultsPHASE2 COMPLETED 55Jul 1, 2013Oct 1, 2013Jun 1, 20151 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Efficacy of Lactulose as a Preparation for Colonoscopy.
at least 3 hours post last consumption

Efficacy assessed by the physician's determination of the cleanliness of the colon using the cumulative Boston Bowel Preparation Scale (BBPS) score. The cumulative score is derived from three segmental scores assessed from the following three colonic segments: right colon, transverse colon, and left colon. Segment scores range from 0 to 3 with the following abbreviated definitions: 0=mucosa not visible; 1=a portion of the mucosa is visible; 2=minor residue, but mucosa is seen well; 3=entire mucosa is seen well with no residue. The cumulative BBPS score is the sum of the three segment scores such that a cumulative score of 9 represents a colon with maximum mucosa visible and a score of 0 represents minimal visibility.

Secondary Endpoints
Incidence of Treatment Failure
at least 3 hours post last consumption
Tolerability of and Preference for Lactulose as a Bowel Evacuant-Patient Visual Analog Scale (VAS)
3 - 15 hours post last consumption
Tolerability of and Preference for Lactulose as a Bowel Evacuant-Likert 1
3-15 hours post last consumption
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingTRIPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Full dose preparation; AM colonoscopyEXPERIMENTALFour hourly doses of lactulose for oral solution are taken in the evening. The colonoscopy is initiated prior to noon on the following day.
Full dose preparation; PM colonoscopyEXPERIMENTALFour hourly doses of lactulose for oral solution are taken in the evening. The colonoscopy is initiated after noon on the following day.
Split dose preparation; AM colonoscopyEXPERIMENTALThree hourly doses of lactulose for oral solution are taken in the evening prior to the day of the colonoscopy procedure; one dose is taken on the morning of the procedure. The colonoscopy is initiated prior to noon.
Split dose preparation; PM colonoscopyEXPERIMENTALThree hourly doses of lactulose for oral solution are taken in the evening prior to the day of the colonoscopy procedure; one dose is taken on the morning of the procedure. The colonoscopy is initiated after noon.
Interventions
NameTypeDescription
Full dose preparationDRUG -
Split dose preparationDRUG -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Patients requiring bowel evacuation for colonoscopy. Exclusion Criteria: * Patients with galactosemia (galactose-sensitive diet). * Patients known to be hypersensitive to any of the components of lactulose for oral solution. * Patients with an abnormality on screening blood ...

Countries:United States
Unlock Eligibility Criteria